At the European Society for the Study of Diabetes (EASD) Annual Meeting in Barcelona, Luis Masana Marín discusses the benefits of PCSK9 inhibitors in clinical practice.
1. What is the mechanism of action of Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors? (0:04)
2. What is known about the use of PCSK inhibitors in patients with diabetes? (1:00)
3. What are the limitations of PCSK9 inhibitors? (2:50)
4. Which diabetes patients will benefit most from this class of drug? (3:57)
5. What factors would you consider when deciding whether to prescribe PCSK9 inhibitors to a patient with diabetes? (5:03)
Luis Masana Marín has no conflicts of interest to declare in relation to this video.
Filmed at the Annual Meeting of the European Association of the Study of Diabetes (EASD) Barcelona, Spain 2019.
Share this Video
Related Videos In Diabetes
Sanjay Kalra: Research Highlights from 2021
We were delighted to speak with our editorial board member Dr Sanjay Kalra (Bharti Hospital, Karnal, India) around last year’s research highlights in the field of diabetes and obesity. Questions In the field of diabetes and obesity, what have been the most exciting research highlights of 2021? (0:32) What is your advice for health care […]
Gian Paolo Fadini, EASD 2021: Real-world Data from the RESTORE-2 Study
touchENDOCRINOLOGY caught up with Prof Gian Paolo Fadini (University Hospital of Padova, Italy) virtually during the EASD Annual Meeting 2021 conference to discuss the real-world data from the RESTORE-2 study. Questions 1. What have randomized controlled trials taught us about the efficacy and safety of second-generation basal insulins? (00:18-01:31) 2. What were the aims, design […]
Anna-Maria Lampousi, EASD 2021: Dietary Factors and Risk of Islet Autoimmunity and Type 1 Diabetes
touchENDOCRINOLOGY caught up with Anna-Maria Lampousi (Karolinska Institutet, Stockholm, Sweden) virtually during the EASD Annual Meeting 2021 conference to discuss her systematic review and meta-analysis on dietary factors and risk of islet autoimmunity and type 1 diabetes. Questions 1. What is known about the associations between dietary components and type 1 diabetes, and what gaps […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!